LINCOLN—Nebraska’s medical cannabis program continues to face delays nearly two years after 71% of voters approved legalization in 2024. Although four cultivation licenses have been issued, manufacturers and dispensaries are still awaiting approval, leaving patients without access to regulated products. Growers have raised concerns about mounting fees and the lack of testing and distribution guidelines, with some regulations potentially taking another one to two years to finalize. Advocates argue the restrictions undermine voter intent, while state Sen. Kathleen Kauth and other officials emphasize the need for additional research and safeguards before expanding access.

Click HERE for the full article